Bristol-Myers/NNP Squibb/NNP Co./NNP ,/, New/NNP York/NNP ,/, the/DT newly/RB merged/VBN drug/NN and/CC health-care-product/NN company/NN ,/, reported/VBD record/NN third-quarter/NN earnings/NNS for/IN both/DT companies/NNS in/IN the/DT merger/NN ./.
Bristol-Myers/NNP Co./NNP and/CC Squibb/NNP Corp./NNP ,/, Princeton/NNP ,/, N.J./NNP ,/, merged/VBD Oct./NNP 4/CD ,/, but/CC the/DT new/JJ company/NN reported/VBD third-period/JJ earnings/NNS for/IN both/DT companies/NNS ./.
For/IN the/DT fourth/JJ quarter/NN ,/, Bristol-Myers/NNP Squibb/NNP will/MD report/VB one/CD set/NN of/IN earnings/NNS ./.
Bristol-Myers/NNP said/VBD 0/-NONE- net/JJ income/NN rose/VBD 15/CD %/NN to/TO $/$ 266.2/CD million/CD *U*/-NONE- ,/, or/CC 93/CD cents/NNS a/DT share/NN ,/, from/IN $/$ 232.3/CD million/CD *U*/-NONE- ,/, or/CC 81/CD cents/NNS a/DT share/NN ,/, a/DT year/NN earlier/RBR ./.
Sales/NNS gained/VBD 5/CD %/NN to/TO $/$ 1.59/CD billion/CD *U*/-NONE- from/IN $/$ 1.52/CD billion/CD *U*/-NONE- ./.
Squibb/NNP Corp./NNP said/VBD 0/-NONE- net/NN rose/VBD 17/CD %/NN to/TO $/$ 144.5/CD million/CD *U*/-NONE- ,/, or/CC $/$ 1.47/CD *U*/-NONE- a/DT share/NN ,/, from/IN $/$ 123/CD million/CD *U*/-NONE- ,/, or/CC $/$ 1.25/CD *U*/-NONE- a/DT share/NN ./.
Sales/NNS were/VBD $/$ 730.1/CD million/CD *U*/-NONE- ,/, up/IN 7/CD %/NN from/IN $/$ 679.5/CD million/CD *U*/-NONE- ./.
In/IN New/NNP York/NNP Stock/NNP Exchange/NNP composite/JJ trading/NN ,/, Bristol-Myers/NNP Squibb/NNP rose/VBD $/$ 1.75/CD *U*/-NONE- to/TO $/$ 52.75/CD *U*/-NONE- ./.

